BLOG

precision_oncology

Elicio Receives $2.8M Grant for Cancer Vaccine Development

NEW YORK – Elicio Therapeutics said Tuesday that it received a $2.8 million grant from the Gastro-Intestinal Research Foundation in Chicago that it will use to develop two cancer vaccines.